Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $36.8500 (-4.41%) ($36.6900 - $38.5000) on Tue. Apr. 9, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.47% (three month average) | RSI | 46 | Latest Price | $36.8500(-4.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.6% a day on average for past five trading days. | Weekly Trend | ATRA advances 1.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -1.735% in a week (0% probabilities). UUP(-14%) VXX(-13%) TLT(-13%) VIXM(-10%) UNG(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.735% (StdDev 3.47%) | Hourly BBV | 0 () | Intraday Trend | -4.3% | | | |
|
Resistance Level | $38.91 | 5 Day Moving Average | $39.42(-6.52%) | 10 Day Moving Average | $39.12(-5.8%) | 20 Day Moving Average | $38.91(-5.29%) | To recent high | -11.7% | To recent low | 8.2% | Market Cap | $2.738b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |